Tom Wagemans

610 total citations
14 papers, 510 citations indexed

About

Tom Wagemans is a scholar working on Physiology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Tom Wagemans has authored 14 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 6 papers in Organic Chemistry and 5 papers in Epidemiology. Recurrent topics in Tom Wagemans's work include Lysosomal Storage Disorders Research (11 papers), Carbohydrate Chemistry and Synthesis (6 papers) and Trypanosoma species research and implications (5 papers). Tom Wagemans is often cited by papers focused on Lysosomal Storage Disorders Research (11 papers), Carbohydrate Chemistry and Synthesis (6 papers) and Trypanosoma species research and implications (5 papers). Tom Wagemans collaborates with scholars based in Netherlands, United Kingdom and Denmark. Tom Wagemans's co-authors include Lodewijk IJlst, Frits A. Wijburg, Naomi van Vlies, Jessica de Ruijter, Ronald J. A. Wanders, Wim Kulik, Carlo W.T. van Roermund, Hans R. Waterham, Willem M. van der Wal and Henk van Lenthe and has published in prestigious journals such as PLoS ONE, Annals of Neurology and Bone.

In The Last Decade

Tom Wagemans

14 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Wagemans Netherlands 12 383 191 147 142 105 14 510
Carmela Zizzo Italy 14 384 1.0× 140 0.7× 137 0.9× 117 0.8× 122 1.2× 34 490
Liming Shu United States 16 348 0.9× 110 0.6× 255 1.7× 148 1.0× 76 0.7× 29 589
Evangelia Dimitriou Greece 14 288 0.8× 161 0.8× 119 0.8× 134 0.9× 75 0.7× 29 491
N. Leslie United States 9 163 0.4× 50 0.3× 121 0.8× 71 0.5× 45 0.4× 14 390
Sun Hee Heo South Korea 10 124 0.3× 54 0.3× 138 0.9× 55 0.4× 41 0.4× 24 311
Patryk Lipiński Poland 11 104 0.3× 34 0.2× 177 1.2× 45 0.3× 45 0.4× 52 326
Gülden Gökçay Türkiye 13 100 0.3× 26 0.1× 277 1.9× 86 0.6× 61 0.6× 30 492
Jaime Anguiano United States 9 54 0.1× 191 1.0× 247 1.7× 99 0.7× 50 0.5× 11 466
Catherine Scott United Kingdom 10 203 0.5× 65 0.3× 239 1.6× 85 0.6× 37 0.4× 15 553
Krishna Seshu Tummala Spain 8 60 0.2× 244 1.3× 286 1.9× 93 0.7× 16 0.2× 9 727

Countries citing papers authored by Tom Wagemans

Since Specialization
Citations

This map shows the geographic impact of Tom Wagemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Wagemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Wagemans more than expected).

Fields of papers citing papers by Tom Wagemans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Wagemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Wagemans. The network helps show where Tom Wagemans may publish in the future.

Co-authorship network of co-authors of Tom Wagemans

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Wagemans. A scholar is included among the top collaborators of Tom Wagemans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Wagemans. Tom Wagemans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Welling, Lindsey, M. J. Valstar, Lies H. Hoefsloot, et al.. (2016). Residual N‐acetyl‐α‐glucosaminidase activity in fibroblasts correlates with disease severity in patients with mucopolysaccharidosis type IIIB. Journal of Inherited Metabolic Disease. 39(3). 437–445. 16 indexed citations
2.
Kingma, Sandra D.K., Tom Wagemans, Lodewijk IJlst, et al.. (2016). Altered interaction and distribution of glycosaminoglycans and growth factors in mucopolysaccharidosis type I bone disease. Bone. 88. 92–100. 22 indexed citations
3.
Langereis, Eveline J., Tom Wagemans, Wim Kulik, et al.. (2015). A Multiplex Assay for the Diagnosis of Mucopolysaccharidoses and Mucolipidoses. PLoS ONE. 10(9). e0138622–e0138622. 30 indexed citations
4.
Kingma, Sandra D.K., Tom Wagemans, Lodewijk IJlst, et al.. (2015). Adverse Effects of Genistein in a Mucopolysaccharidosis Type I Mouse Model. JIMD Reports. 23. 77–83. 18 indexed citations
5.
Kingma, Sandra D.K., Tom Wagemans, Lodewijk IJlst, et al.. (2015). A study on the influence of glycosaminoglycan and growth factor interaction in mucopolysaccharidosis type I bone disease. Molecular Genetics and Metabolism. 114(2). S63–S63. 1 indexed citations
6.
Langereis, Eveline J., Naomi van Vlies, Heather J. Church, et al.. (2014). Biomarker responses correlate with antibody status in mucopolysaccharidosis type I patients on long-term enzyme replacement therapy. Molecular Genetics and Metabolism. 114(2). 129–137. 47 indexed citations
7.
Kingma, Sandra D.K., Tom Wagemans, Lodewijk IJlst, Frits A. Wijburg, & Naomi van Vlies. (2014). Genistein increases glycosaminoglycan levels in mucopolysaccharidosis type I cell models. Journal of Inherited Metabolic Disease. 37(5). 813–821. 15 indexed citations
8.
Roermund, Carlo W.T. van, Lodewijk IJlst, Tom Wagemans, Ronald J. A. Wanders, & Hans R. Waterham. (2013). A role for the human peroxisomal half-transporter ABCD3 in the oxidation of dicarboxylic acids. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1841(4). 563–568. 82 indexed citations
9.
Vlies, Naomi van, et al.. (2013). Heparan sulfate and dermatan sulfate disaccharide levels for newborn screening in MPS I, MPS II and MPS III. Molecular Genetics and Metabolism. 108(2). S95–S95. 1 indexed citations
10.
Kingma, Sandra D.K., Eveline J. Langereis, Lida Zoetekouw, et al.. (2013). An algorithm to predict phenotypic severity in mucopolysaccharidosis type I in the first month of life. Orphanet Journal of Rare Diseases. 8(1). 99–99. 29 indexed citations
11.
Ruijter, Jessica de, Lodewijk IJlst, Wim Kulik, et al.. (2012). Heparan sulfate derived disaccharides in plasma and total urinary excretion of glycosaminoglycans correlate with disease severity in Sanfilippo disease. Journal of Inherited Metabolic Disease. 36(2). 271–279. 23 indexed citations
13.
Ruijter, Jessica de, Minke H. de Ru, Tom Wagemans, et al.. (2012). Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III. Molecular Genetics and Metabolism. 107(4). 705–710. 90 indexed citations
14.
Ruijter, Jessica de, M. J. Valstar, Magdalena Narajczyk, et al.. (2011). Genistein in Sanfilippo disease: A randomized controlled crossover trial. Annals of Neurology. 71(1). 110–120. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026